Autologous
Exosome Therapy
Autologous exosome therapy utilises extracellular vesicles derived from the patient's own blood or adipose tissue to deliver targeted regenerative signals at a cellular level. Unlike plant-based or allogeneic exosome preparations, autologous exosomes carry the patient's own biological information — eliminating immunogenic risk and enabling direct intercellular communication that stimulates tissue repair, dermal regeneration, and follicular restoration in the precise treatment area.
Exosomes are derived exclusively from the patient's own biological material, they integrate with the body's existing cellular signalling pathways without immunogenic interference — activating endogenous repair mechanisms to stimulate tissue regeneration, restore dermal integrity at a structural level, and reactivate follicular function through precise, patient-specific intercellular communication.
Benefits of Autologous Exosome Therapy
Dermal Remodelling and Structural Restoration: Autologous exosomes stimulate fibroblast proliferation, de novo collagen and elastin synthesis, and extracellular matrix remodelling — improving dermal architecture, skin texture, and structural integrity at a cellular level.
Follicular Stem Cell Reactivation: Exosomal signalling reactivates dormant follicular stem cells and prolongs the anagen (active growth) phase of the hair cycle, restoring measurable improvements in hair density, shaft diameter, and follicular count.
Accelerated Tissue Repair and Post-Procedural Recovery: Exosomes modulate the inflammatory cascade, promote angiogenesis, and accelerate cellular turnover — significantly reducing recovery time following injury, surgery, or procedural dermatological treatment.
Mitigation of Intrinsic Cellular Ageing: Exosomal cargo — including miRNA and regulatory signalling proteins — counteracts oxidative DNA damage, suppresses pro-inflammatory cytokine activity, and restores cellular homeostasis, directly addressing the underlying biological mechanisms of intrinsic skin ageing and cellular senescence.
Why Choose Autologous Exosome Therapy at Dr Jinah Yoo Regenerative Centre?
Autologous Origin — Eliminated Immunogenic Risk: Because exosomes are isolated exclusively from the patient's own biological material, the risk of immune rejection, allergic response, or adverse systemic reaction is effectively eliminated — enabling a precisely personalised treatment protocol aligned with the patient's unique cellular profile.
Advanced Processing for Optimal Biological Activity: Exosomes are isolated using controlled centrifugation and filtration protocols that preserve vesicle integrity and maintain the concentration of bioactive growth factors, miRNA, and signalling proteins required for clinically meaningful therapeutic outcomes.
Direct Intradermal Delivery for Maximum Efficacy: Unlike topically applied or plant-derived exosome preparations, autologous exosomes are administered via microinjection directly into the target tissue — ensuring precise localisation, optimal bioavailability, and clinically validated outcomes across dermal regeneration, follicular restoration, and systemic tissue repair.
Rated 5 star by hundred’s of people across the UK, USA and Korea...
Excellent
Best on the market
Best on the market
Best on the market
Best on the market
Best on the market
Best on the market
Best on the market
Best on the market
Best on the market
Rated 5 star by hundred’s of people across the UK, USA and Korea...
The staff was welcoming, and the therapist was knowledgeable and attentive. The clinic is clean and modern, and I am very pleased with my treatment results. Highly recommend!
I had a great experience here at Dr Jinah Yoo! I had the ‘brightening’ treatment after having too much sunburn on my summer vacation and it really helped. The process was very enjoyable thanks to the skillful and gentle practitioner. I will come back in the future if I have any needs for skin improvements!
A perfect experience! I had the rf facial which is for lift up. The therapist is very professional and the environment is also very helpful for relaxing. Nice location as well.
Absolutely love the place. Had some moles removed from my face by Dr Yoo. A week later there is not the slightest indication that there was ever even anything there. Results are incredible.
Based in Mayfair, London
Pioneered by Dr. Jinah Yoo
Dr Jinah Yoo is a Korean UK-trained consultant dermatologist who is the founder and medical director of Dr Jinah Yoo Dermatology.
Dr Yoo has completed intensive dermatology training and developed special interest in cosmetic dermatology, hyperpigmentary disorders and skin lymphoma. She has completed two Master’s degrees in addition to her medical training and has been awarded Distinction in MSc (Skin Ageing and Aesthetic Medicine) at the University of Manchester. Spending the final year of her MSc doing her projects on facial hyperpigmentation equipped her with scientific knowledge on aetiology and evidence-based approach in the management of hyperpigmentation.
She attended numerous observerships at the World’s leading pigment/cosmetic dermatology clinics in USA, Singapore and South Korea and established the first NHS-based hyperpigmentation service at Queen Elizabeth Hospital in 2018.
She has been elected to Royal College of Physician fellowship (FRCP) for her ongoing contribution to the advances in dermatology specialty. She is actively involved in education and research and her works are regularly presented at national/international conferences and published in peer-review journals.
FREQUENTLY ASKED QUESTIONS
Autologous Exosome Therapy FAQ’s
What’s the difference between autologous and plant-based exosomes?
Autologous exosomes are extracellular vesicles derived from the patient's own blood or adipose tissue. Because they carry the patient's unique biological identity, they integrate naturally with the body's cellular signalling systems and eliminate any risk of immune rejection or adverse reaction. Plant-based exosomes — derived from sources such as ginger or grapes — are allogeneic preparations that lack patient-specific biological information and carry a higher theoretical risk of immunogenic response. Autologous preparations are considered the gold standard for clinical regenerative medicine applications.
Is the procedure painful?
The procedure involves microinjections into the dermis or scalp, which are well-tolerated by most patients. A topical anaesthetic cream is applied prior to treatment to minimise discomfort. The injection process itself is brief, and most patients describe only mild pressure or superficial sensitivity. Post-procedure discomfort is typically minimal and resolves within a few hours.
How long will results last?
Results develop progressively as the exosomes activate endogenous repair pathways and stimulate collagen synthesis. Initial improvements in skin texture and tone are typically observed within 4–6 weeks. Structural dermal improvements and follicular responses continue to develop over 3–6 months. Longevity of results varies by individual, treatment indication, and lifestyle factors, but clinical outcomes are generally sustained for 12–18 months. A maintenance protocol can be recommended to extend results.
How does autologous exosome therapy differ from other regenerative treatments?
Compared to PRP (platelet-rich plasma), autologous exosomes contain a significantly more concentrated payload of bioactive molecules — including growth factors, miRNA, and signalling proteins — that act with greater precision at the cellular level. Unlike stem cell therapies, exosomes do not introduce live cells into the body, reducing procedural complexity and regulatory risk. Unlike allogeneic or plant-derived exosomes, autologous preparations carry no immunogenic risk. The result is a highly targeted, biologically compatible regenerative therapy with a well-established safety profile.
What conditions can autologous exosome therapy address?
Autologous exosome therapy is clinically applicable to a range of dermatological and regenerative indications, including: androgenetic alopecia and diffuse hair thinning; post-inflammatory or post-procedural skin repair; photoageing, dermal atrophy, and loss of structural integrity; acne scarring and textural irregularities; skin conditions with an inflammatory or barrier-compromised component; and as an adjunct therapy following laser resurfacing, microneedling, or surgical procedures to accelerate healing and optimise outcomes.
Are there risks of allergic reactions with autologous exosome therapy?
Since the exosomes are derived from your own cells, the risk of allergic reactions or immune response is minimal, making it a safer alternative compared to treatments using foreign substances.
How does autologous exosome therapy contribute to hair restoration?
The exosomes contain growth factors that stimulate dormant hair follicles, promoting hair regrowth and improving hair density. This makes it a promising option for individuals experiencing hair loss.
What is the role of exosomes in skin rejuvenation?
Exosomes function as intercellular communication vehicles, transferring bioactive cargo — including growth factors, cytokines, lipids, and non-coding RNA — between cells. In the context of skin regeneration, exosomal signalling stimulates fibroblast proliferation, collagen and elastin synthesis, keratinocyte migration, and angiogenesis. They also modulate the inflammatory response, suppressing pro-inflammatory cytokine activity while promoting a reparative cellular environment. This multi-pathway mechanism makes exosomes among the most sophisticated tools available in regenerative dermatology.
How are blood cells involved in autologous exosome therapy?
In autologous exosome therapy, exosomes are derived from blood cells or fat tissue, ensuring the treatment is personalised and biocompatible. These exosomes work by communicating with surrounding cells, stimulating skin regeneration, tissue repair, and collagen production, making the therapy highly effective for rejuvenating skin and promoting healing.
